{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:43:32Z","timestamp":1780501412855,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T00:00:00Z","timestamp":1683417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["212102310046"],"award-info":[{"award-number":["212102310046"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical science and technology research project","award":["SBGJ202003001"],"award-info":[{"award-number":["SBGJ202003001"]}]},{"name":"Opening Foundation of National Health Commission Key Laboratory of Birth Defects Prevention","award":["ZD202006"],"award-info":[{"award-number":["ZD202006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the past decade, <jats:italic>SETBP1<\/jats:italic> has attracted a lot of interest on that the same gene with different type or level (germline or somatic) of variants could provoke different pathologic consequences such as Schinzel-Giedon syndrome, SETBP1 Haploinsufficiency Disorder (SETBP1-HD) and myeloid malignancies. Whole exome sequencing was conducted to detect the etiology of a pregnant woman with mental retardation. As a new oncogene and potential marker of myeloid malignancies, somatic <jats:italic>SETBP1<\/jats:italic> variants in other cancers were rarely studied. We performed a pan-cancer analysis of <jats:italic>SETBP1<\/jats:italic> gene in different cancers for the first time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A novel heterozygous mutation of the <jats:italic>SETBP1<\/jats:italic> gene (c.1724_1727del, p.D575Vfs*4) was found in the patient and the fetus and the mutation was predicted to result in a truncated protein. Reduced <jats:italic>SETBP1<\/jats:italic> expression was associated with SETBP1-HD. The pan-cancer analysis of <jats:italic>SETBP1<\/jats:italic> showed that <jats:italic>SETBP1<\/jats:italic> overexpression should be given special attention in Bladder Urothelial Carcinoma (BLCA) and Stomach adenocarcinoma (STAD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The de novo <jats:italic>SETBP1<\/jats:italic> mutation was the genetic cause of SETBP1-HD in the family. BLCA and STAD might be related to <jats:italic>SETBP1<\/jats:italic> overexpression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02705-6","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:01:17Z","timestamp":1683478877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6498-9979","authenticated-orcid":false,"given":"Hongdan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,7]]},"reference":[{"issue":"5","key":"2705_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1046\/j.1432-1327.2001.02000.x","volume":"268","author":"M Minakuchi","year":"2001","unstructured":"Minakuchi M, Kakazu N, Gorrin-Rivas MJ, Abe T, Copeland TD, Ueda K, Adachi Y. Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET. Eur J Biochem. 2001;268(5):1340\u201351.","journal-title":"Eur J Biochem"},{"issue":"6","key":"2705_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/ng.581","volume":"42","author":"A Hoischen","year":"2010","unstructured":"Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M, de Vries P, de Reuver R, Wieskamp N, Mortier G, Devriendt K, Amorim MZ, Revencu N, Kidd A, Barbosa M, Turner A, Smith J, Oley C, Henderson A, Hayes IM, Thompson EM, Brunner HG, de Vries BB, Veltman JA. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet. 2010;42(6):483\u20135.","journal-title":"Nat Genet"},{"issue":"6","key":"2705_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12185-017-2241-1","volume":"105","author":"H Makishima","year":"2017","unstructured":"Makishima H. Somatic SETBP1 mutations in myeloid neoplasms. Int J Hematol. 2017;105(6):732\u201342.","journal-title":"Int J Hematol"},{"issue":"1","key":"2705_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni C, Papaemmanuil E, Schnittger S, Kim DW, Boultwood J, Rossi F, Gaipa G, De Martini GP, di Celle PF, Jang HG, Fantin V, Bignell GR, Magistroni V, Haferlach T, Pogliani EM, Campbell PJ, Chase AJ, Tapper WJ, Cross NC, Gambacorti-Passerini C. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45(1):18\u201324.","journal-title":"Nat Genet"},{"issue":"1","key":"2705_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12041-017-0877-5","volume":"97","author":"WL Liu","year":"2018","unstructured":"Liu WL, He ZX, Li F, Ai R, Ma HW. Schinzel-Giedion syndrome: a novel case, review and revised diagnostic criteria. J Genet. 2018;97(1):35\u201346.","journal-title":"J Genet"},{"issue":"3","key":"2705_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejmg.2012.01.005","volume":"55","author":"G Marseglia","year":"2012","unstructured":"Marseglia G, Scordo MR, Pescucci C, Nannetti G, Biagini E, Scandurra V, Gerundino F, Magi A, Benelli M, Torricelli F. 372 kb microdeletion in 18q12.3 causing SETBP1 haploinsufficiency associated with mild mental retardation and expressive speech impairment. Eur J Med Genet. 2012;55(3):216\u201321.","journal-title":"Eur J Med Genet"},{"issue":"4","key":"2705_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ajmg.1320010402","volume":"1","author":"A Schinzel","year":"1978","unstructured":"Schinzel A, Giedion A. A syndrome of severe midface retraction, multiple skull anomalies, clubfeet, and cardiac and renal malformations in sibs. Am J Med Genet. 1978;1(4):361\u201375.","journal-title":"Am J Med Genet"},{"issue":"9","key":"2705_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejmg.2015.07.004","volume":"58","author":"Y Herenger","year":"2015","unstructured":"Herenger Y, Stoetzel C, Schaefer E, Scheidecker S, Mani\u00e8re MC, Pelletier V, Alembik Y, Christmann D, Clavert JM, Terzic J, Fischbach M, De Saint MA, Dollfus H. Long term follow up of two independent patients with Schinzel-Giedion carrying SETBP1 mutations. Eur J Med Genet. 2015;58(9):479\u201387.","journal-title":"Eur J Med Genet"},{"issue":"8","key":"2705_CR9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/s41431-021-00888-9","volume":"29","author":"NA Jansen","year":"2021","unstructured":"Jansen NA, Braden RO, Srivastava S, Otness EF, Lesca G, Rossi M, Nizon M, Bernier RA, Quelin C, van Haeringen A, Kleefstra T, Wong MMK, Whalen S, Fisher SE, Morgan AT, van Bon BW. Clinical delineation of SETBP1 haploinsufficiency disorder. Eur J Hum Genet. 2021;29(8):1198\u2013205.","journal-title":"Eur J Hum Genet"},{"key":"2705_CR10","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet]","author":"A Morgan","year":"2021","unstructured":"Morgan A, Srivastava S, Duis J, van Bon B. SETBP1 haploinsufficiency disorder. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle: University of Washington; 2021. p. 1993\u20132022."},{"issue":"4","key":"2705_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/leu.2014.301","volume":"29","author":"D Inoue","year":"2015","unstructured":"Inoue D, Kitaura J, Matsui H, Hou HA, Chou WC, Nagamachi A, Kawabata KC, Togami K, Nagase R, Horikawa S, Saika M, Micol JB, Hayashi Y, Harada Y, Harada H, Inaba T, Tien HF, Abdel-Wahab O, Kitamura T. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS. Leukemia. 2015;29(4):847\u201357.","journal-title":"Leukemia"},{"issue":"52","key":"2705_CR12","doi-asserted-by":"publisher","first-page":"86300","DOI":"10.18632\/oncotarget.13383","volume":"7","author":"N Nguyen","year":"2016","unstructured":"Nguyen N, Vishwakarma BA, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y. Myb expression is critical for myeloid leukemia development induced by Setbp1 activation. Oncotarget. 2016;7(52):86300\u201312.","journal-title":"Oncotarget"},{"issue":"4","key":"2705_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/leu.2015.337","volume":"30","author":"CC Mason","year":"2016","unstructured":"Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Zabriskie MS, Yan D, Pomicter AD, Reynolds KR, Eiring AM, Kronenberg Z, Sherman RL, Tyner JW, Dalley BK, Dao KH, Yandell M, Druker BJ, Gotlib J, O\u2019Hare T, Deininger MW. Age-related mutations and chronic myelomonocytic leukemia. Leukemia. 2016;30(4):906\u201313.","journal-title":"Leukemia"},{"issue":"5","key":"2705_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.prp.2018.03.010","volume":"214","author":"XY Yao","year":"2018","unstructured":"Yao XY, Zhou JD, Yang J, Zhang W, Ma JC, Wen XM, Yao DM, Xu ZJ, Wu DH, He PF, Qian J, Lin J. SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Pathol Res Pract. 2018;214(5):706\u201312.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"2705_CR15","doi-asserted-by":"publisher","first-page":"e1006683","DOI":"10.1371\/journal.pgen.1006683","volume":"13","author":"R Acuna-Hidalgo","year":"2017","unstructured":"Acuna-Hidalgo R, Deriziotis P, Steehouwer M, Gilissen C, Graham SA, van Dam S, Hoover-Fong J, Telegrafi AB, Destree A, Smigiel R, Lambie LA, Kayserili H, Altunoglu U, Lapi E, Uzielli ML, Aracena M, Nur BG, Mihci E, Moreira LM, Borges Ferreira V, Horovitz DD, da Rocha KM, Jezela-Stanek A, Brooks AS, Reutter H, Cohen JS, Fatemi A, Smitka M, Grebe TA, Di Donato N, Deshpande C, Vandersteen A, Marques Louren\u00e7o C, Dufke A, Rossier E, Andre G, Baumer A, Spencer C, McGaughran J, Franke L, Veltman JA, De Vries BB, Schinzel A, Fisher SE, Hoischen A, van Bon BW. Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies. PLoS Genet. 2017;13(3):e1006683.","journal-title":"PLoS Genet"},{"issue":"1","key":"2705_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13023-020-01492-8","volume":"15","author":"HD Wang","year":"2020","unstructured":"Wang HD, Guo LJ, Feng ZQ, Zhang DW, Zhang MT, Gao Y, Chen CL, Zhu BF. Cloning, expression and enzyme activity delineation of two novel CANT1 mutations: the disappearance of dimerization may indicate the change of protein conformation and even function. Orphanet J Rare Dis. 2020;15(1):240.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2705_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):41.","journal-title":"Genome Biol"},{"issue":"7283","key":"2705_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899\u2013905.","journal-title":"Nature"},{"key":"2705_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00073","author":"R Bonneville","year":"2017","unstructured":"Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen HZ, Reeser JW, Yu L, Roychowdhury S. Landscape of microsatellite instability across 39 cancer types. JCO Precis Oncol. 2017. https:\/\/doi.org\/10.1200\/PO.17.00073.","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"2705_CR20","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/s41467-018-04462-8","volume":"9","author":"R Piazza","year":"2018","unstructured":"Piazza R, Magistroni V, Redaelli S, Mauri M, Massimino L, Sessa A, Peronaci M, Lalowski M, Soliymani R, Mezzatesta C, Pirola A, Banfi F, Rubio A, Rea D, Stagno F, Usala E, Martino B, Campiotti L, Merli M, Passamonti F, Onida F, Morotti A, Pavesi F, Bregni M, Broccoli V, Baumann M, Gambacorti-Passerini C. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub. Nat Commun. 2018;9(1):2192.","journal-title":"Nat Commun"},{"issue":"2","key":"2705_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/jmg.2010.084582","volume":"48","author":"I Filges","year":"2011","unstructured":"Filges I, Shimojima K, Okamoto N, R\u00f6thlisberger B, Weber P, Huber AR, Nishizawa T, Datta AN, Miny P, Yamamoto T. Reduced expression by SETBP1 haploinsufficiency causes developmental and expressive language delay indicating a phenotype distinct from Schinzel-Giedion syndrome. J Med Genet. 2011;48(2):117\u201322.","journal-title":"J Med Genet"},{"issue":"6","key":"2705_CR22","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1002\/jcb.28339","volume":"120","author":"H Liu","year":"2019","unstructured":"Liu H, Liu J, Si L, Guo C, Liu W, Liu Y. GDF-15 promotes mitochondrial function and proliferation in neuronal HT22 cells. J Cell Biochem. 2019;120(6):10530\u201347.","journal-title":"J Cell Biochem"},{"issue":"2","key":"2705_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41593-019-0545-6","volume":"23","author":"ML Bennett","year":"2020","unstructured":"Bennett ML, Bennett FC. The influence of environment and origin on brain resident macrophages and implications for therapy. Nat Neurosci. 2020;23(2):157\u201366.","journal-title":"Nat Neurosci"},{"key":"2705_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.01.002","volume":"149\u2013150","author":"CA Mosser","year":"2017","unstructured":"Mosser CA, Baptista S, Arnoux I, Audinat E. Microglia in CNS development: shaping the brain for the future. Prog Neurobiol. 2017;149\u2013150:1\u201320.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2705_CR25","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1038\/s41598-021-87828-1","volume":"11","author":"M Baek","year":"2021","unstructured":"Baek M, Yoo E, Choi HI, An GY, Chai JC, Lee YS, Jung KH, Chai YG. The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line. Sci Rep. 2021;11(1):8828.","journal-title":"Sci Rep"},{"issue":"31","key":"2705_CR26","doi-asserted-by":"publisher","first-page":"51920","DOI":"10.18632\/oncotarget.17231","volume":"8","author":"N Coccaro","year":"2017","unstructured":"Coccaro N, Tota G, Zagaria A, Anelli L, Specchia G, Albano F. SETBP1 dysregulation in congenital disorders and myeloid neoplasms. Oncotarget. 2017;8(31):51920\u201335.","journal-title":"Oncotarget"},{"key":"2705_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40364-017-0113-8","volume":"5","author":"K Linder","year":"2017","unstructured":"Linder K, Iragavarapu C, Liu D. SETBP1 mutations as a biomarker for myelodysplasia\/myeloproliferative neoplasm overlap syndrome. Biomark Res. 2017;5:33.","journal-title":"Biomark Res"},{"issue":"8","key":"2705_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ng.2696","volume":"45","author":"H Makishima","year":"2013","unstructured":"Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, Ng KP, Gudmundsson KO, Vishwakarma BA, Jerez A, Gomez-Segui I, Takahashi M, Shiraishi Y, Nagata Y, Guinta K, Mori H, Sekeres MA, Chiba K, Tanaka H, Muramatsu H, Sakaguchi H, Paquette RL, McDevitt MA, Kojima S, Saunthararajah Y, Miyano S, Shih LY, Du Y, Ogawa S, Maciejewski JP. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet. 2013;45(8):942\u20136.","journal-title":"Nat Genet"},{"issue":"9","key":"2705_CR29","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/leu.2013.133","volume":"27","author":"M Meggendorfer","year":"2013","unstructured":"Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger S. SETBP1 mutations occur in 9% of MDS\/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia. 2013;27(9):1852\u201360.","journal-title":"Leukemia"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02705-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02705-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:01:22Z","timestamp":1683478882000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02705-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02705-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,7]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Henan Provincial People\u2019s Hospital ((2019) Ethics Review No.134). Written informed consent was obtained from the parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0A, B.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}